Libtra 250mg/500mg Tablet
Marketer
DR. LBR Medi Care & Research Private Limited
Salt Composition
Mefenamic Acid (250mg) + Tizanidine (500mg)
Overview Libtra 250mg/500mg Tablet
Abdominal cramp relief is provided by the medication, Libtra 250mg/500mg Tablet. Its action involves relaxing stomach and intestinal muscles, thus halting spasms and alleviating associated pain, bloating, and discomfort. For optimal absorption and reduced stomach upset, ingest Libtra 250mg/500mg Tablet with food, adhering strictly to your physician's prescribed dosage and duration. Exceeding the recommended dose or treatment length is strongly discouraged. Commonly reported side effects include nausea, vomiting, diarrhea, dyspepsia, decreased appetite, somnolence, asthenia, and dry mouth. Persistent or worsening side effects necessitate immediate consultation with your doctor, who can offer strategies for mitigation. Prior to commencing treatment, disclose all pre-existing medical conditions and medications to your physician to ensure treatment safety. Pregnant or lactating individuals should seek medical advice before using this medication.
Primary Ingredients of Libtra 250mg/500mg Tablet
No information provided. Please provide the text you wish to be rephrased.
Uses of Libtra 250mg/500mg Tablet
Stomach spasm
Major Benefits of Libtra 250mg/500mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 250mg/500mg Libtra tablet whole; avoid crushing, chewing, or breaking it. Administer this medication with food.
Common Side effects of Libtra 250mg/500mg Tablet:
- Nausea
- Vomiting
- Diarrhea
- Indigestion
- Loss of appetite
- Sleepiness
- Weakness
- Dryness in mouth
- Heartburn
How to use Libtra 250mg/500mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 250mg/500mg Libtra tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.
How Libtra 250mg/500mg Tablet works:
Libtra 250mg/500mg tablets combine mefenamic acid and tizanidine to alleviate abdominal discomfort. Mefenamic acid, a non-steroidal anti-inflammatory drug (NSAID), inhibits the production of pain and inflammation-inducing chemicals, reducing redness and swelling. Tizanidine, a muscle relaxant, targets the brain and spinal cord to ease muscle tension and spasms.
SAFETY ADVICE
AlcoholUNSAFE
Combining Libtra 250mg/500mg tablets with alcohol is hazardous.
PregnancyCONSULT YOUR DOCTOR
The use of Libtra 250mg/500mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible dangers before prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Libtra 250mg/500mg tablets while breastfeeding is likely inadvisable. Preliminary human evidence indicates potential drug transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking Libtra 250mg/500mg tablets can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these side effects.
KidneyCAUTION
Patients with kidney impairment should use Libtra 250mg/500mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Libtra 250mg/500mg tablets cautiously, potentially requiring dosage modification. Consult a physician. Libtra 250mg/500mg tablets are contraindicated in patients with severe hepatic dysfunction. Baseline and periodic liver function tests are recommended.
What if you forget to take Libtra 250mg/500mg Tablet :
Should you forget a Libtra 250mg/500mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Libtra 250mg/500mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Pain Relievers |
3,018 People bought this recently